InvestorsHub Logo
Followers 4
Posts 282
Boards Moderated 0
Alias Born 12/08/2015

Re: buylowsellhighcanada post# 3541

Tuesday, 07/11/2017 8:49:59 AM

Tuesday, July 11, 2017 8:49:59 AM

Post# of 6013
ISOL Records June Sales of $1,843,173
Isodiol International Inc. Announces Corporate Update
 
 

 
VANCOUVER, July 11, 2017 /CNW/ - Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (Frankfurt: LB6A.F) (the "Company" or "Isodiol") a global cannabis innovator specializing in the development of pharmaceutical and consumer products, today released its unaudited consolidated sales figures for the month of June 2017. The company recorded sales of $1,843,173 CAD for the thirty-day period ended June 30, 2017.  Total quarterly sales were $4,919,693 CAD for the period April 1st to June 30th, 2017.
Isodiol International CEO Marcos Agramont stated, "We continue to expand our domestic footprint and expand our distribution channels for our product lines.  Month over month, we have grown by 10% and will continue to expand our sales and marketing team.  With the progress we have made in Latin America and with our domestic growth, we are very excited entering the second half of 2017."
About Isodiol International Inc.
Isodiol International, Inc. is the market leader in pharmaceutical grade cannabis compounds and the industry leader in manufacturing and development of consumer products. Isodiol's nutraceutical division is the pioneer of many firsts for Hemp-derived cannabinoids, micro-encapsulation, and nano technology for the highest quality consumable and topical skin care products. 
Isodiol's growth strategy includes the development of over-the-counter and pharmaceutical drugs, seeking joint ventures and acquisitions to expand its portfolio of brands and subsidiaries and will aggressively continue International expansion into Latin America, Asia and Europe.


Read more at http://www.stockhouse.com/companies/bullboard?symbol=c.isol&postid=26454413#cLDWG1VFEcAZMgBQ.99